Overview
46,XX difference of sex development (DSD) induced by exogenous maternal-derived androgen is a rare condition in which a baby who is genetically female (having two X chromosomes, or 46,XX) is born with genitals that appear more masculine or ambiguous. This happens because the baby was exposed to unusually high levels of male-type hormones (androgens) during pregnancy, and these hormones came from the mother rather than from the baby's own body. Sources of excess maternal androgens can include certain medications the mother took during pregnancy (such as some older forms of progesterone or anabolic steroids), or rarely, hormone-producing tumors in the mother such as an ovarian or adrenal tumor. The degree of genital changes in the baby can vary widely. Some babies may have only mild enlargement of the clitoris, while others may have more significant changes such as partial fusion of the labial folds or a urogenital sinus (where the urethra and vagina share a common opening). Importantly, the internal reproductive organs — the uterus, fallopian tubes, and ovaries — are typically completely normal because the androgen exposure only affects the external genitals during a specific window of fetal development. Once the source of excess androgen is removed (for example, the mother stops taking the medication or the tumor is treated), no further masculinization occurs after birth. Treatment depends on the degree of genital changes and may include surgical correction if needed, hormone monitoring, and psychological support. With appropriate care, individuals with this condition generally have normal fertility and a normal life expectancy. The condition is also sometimes referred to as maternal androgen-induced virilization of a 46,XX fetus or exogenous androgen-induced female pseudohermaphroditism, though the latter term is now considered outdated.
Also known as:
Key symptoms:
Enlarged clitoris at birthAmbiguous-looking genitals in a newborn girlPartial fusion of the labia (outer genital folds)Single opening for the urethra and vagina (urogenital sinus)Normal internal female organs (uterus, ovaries, fallopian tubes)Normal female chromosomes (46,XX)No ongoing masculinization after birth once androgen source is removedPossible darkening of genital skin
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for 46,XX difference of sex development induced by exogenous maternal-derived androgen.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for 46,XX difference of sex development induced by exogenous maternal-derived androgen at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for 46,XX difference of sex development induced by exogenous maternal-derived androgen.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to 46,XX difference of sex development induced by exogenous maternal-derived androgen.
Community
No community posts yet. Be the first to share your experience with 46,XX difference of sex development induced by exogenous maternal-derived androgen.
Start the conversation →Latest news about 46,XX difference of sex development induced by exogenous maternal-derived androgen
No recent news articles for 46,XX difference of sex development induced by exogenous maternal-derived androgen.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Has congenital adrenal hyperplasia been completely ruled out as a cause?,What was the likely source of the androgen exposure during pregnancy?,Are my child's internal reproductive organs (uterus, ovaries) completely normal?,Is surgery recommended, and if so, what are the risks and benefits of operating now versus waiting?,Will my child go through normal puberty and have normal fertility?,Can you refer us to a psychologist experienced with differences of sex development?,Are there support groups or other families we can connect with?
Common questions about 46,XX difference of sex development induced by exogenous maternal-derived androgen
What is 46,XX difference of sex development induced by exogenous maternal-derived androgen?
46,XX difference of sex development (DSD) induced by exogenous maternal-derived androgen is a rare condition in which a baby who is genetically female (having two X chromosomes, or 46,XX) is born with genitals that appear more masculine or ambiguous. This happens because the baby was exposed to unusually high levels of male-type hormones (androgens) during pregnancy, and these hormones came from the mother rather than from the baby's own body. Sources of excess maternal androgens can include certain medications the mother took during pregnancy (such as some older forms of progesterone or anabo
How is 46,XX difference of sex development induced by exogenous maternal-derived androgen inherited?
46,XX difference of sex development induced by exogenous maternal-derived androgen follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does 46,XX difference of sex development induced by exogenous maternal-derived androgen typically begin?
Typical onset of 46,XX difference of sex development induced by exogenous maternal-derived androgen is neonatal. Age of onset can vary across affected individuals.